Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 13 February 1998:
Vol. 279. no. 5353, pp. 1054 - 1057
DOI: 10.1126/science.279.5353.1054
Prev | Table of Contents

Reports

The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid Polymorphism

Joke M. M. den Haan, * Leslie M. Meadows, * Wei Wang, * Jos Pool, * Els Blokland, Tracie L. Bishop, Carla Reinhardus, Jeffrey Shabanowitz, Rienk Offringa, Donald F. Hunt, Victor H. Engelhard, Els Goulmy dagger

The minor histocompatibility antigen (mHag) HA-1 is the only known mHag for which mismatching is correlated with the development of severe graft versus host disease (GvHD) after human leukocyte antigen-identical bone marrow transplantation. HA-1 was found to be a nonapeptide derived from an allele of the KIAA0223 gene. The HA-1-negative allelic counterpart encoded by KIAA0223 had one amino acid difference from HA-1. Family analysis with HA-1 allele-specific polymerase chain reaction showed an exact correlation between this allelic polymorphism and the HA-1 phenotype. HA-1 allele typing of donor and recipient should improve donor selection and allow the determination of bone marrow transplantation recipients with high risk for HA-1-induced GvHD development.

J. M. M. den Haan, J. Pool, E. Blokland, C. Reinhardus, R. Offringa, E. Goulmy, Department of Immunohematology and Bloodbank, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
L. M. Meadows, T. L. Bishop, J. Shabanowitz, Department of Chemistry, University of Virginia, Charlottesville, VA 22901, USA.
W. Wang and V. H. Engelhard, Department of Microbiology and the Beirne Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
D. F. Hunt, Departments of Chemistry and Pathology, University of Virginia, Charlottesville, VA 22901, USA.
*   These authors contributed equally to this work.

dagger    To whom correspondence should be addressed. E-mail: ihbsecr{at}euronet.nl

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
HapMap scanning of novel human minor histocompatibility antigens.
M. Kamei, Y. Nannya, H. Torikai, T. Kawase, K. Taura, Y. Inamoto, T. Takahashi, M. Yazaki, S. Morishima, K. Tsujimura, et al. (2009)
Blood 113, 5041-5048
   Abstract »    Full Text »    PDF »
Steric Hindrance and Fast Dissociation Explain the Lack of Immunogenicity of the Minor Histocompatibility HA-1Arg Null Allele.
E. Spierings, S. Gras, J.-B. Reiser, B. Mommaas, M. Almekinders, M. G. D. Kester, A. Chouquet, M. Le Gorrec, J. W. Drijfhout, F. Ossendorp, et al. (2009)
J. Immunol. 182, 4809-4816
   Abstract »    Full Text »    PDF »
Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
L. Hambach, K.-W. Ling, J. Pool, Z. Aghai, E. Blokland, H. J. Tanke, J. A. Bruijn, H. Halfwerk, H. van Boven, B. Wieles, et al. (2009)
Blood 113, 2715-2722
   Abstract »    Full Text »    PDF »
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
S. Nicholls, K. P. Piper, F. Mohammed, T. R. Dafforn, S. Tenzer, M. Salim, P. Mahendra, C. Craddock, P. van Endert, H. Schild, et al. (2009)
PNAS 106, 3889-3894
   Abstract »    Full Text »    PDF »
Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells.
W. J. Norde, I. M. Overes, F. Maas, H. Fredrix, J. C. M. Vos, M. G. D. Kester, R. van der Voort, I. Jedema, J. H. F. Falkenburg, A. V. Schattenberg, et al. (2009)
Blood 113, 2312-2323
   Abstract »    Full Text »    PDF »
Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis.
R. M. Spaapen, H. M. Lokhorst, K. van den Oudenalder, B. E. Otterud, H. Dolstra, M. F. Leppert, M. C. Minnema, A. C. Bloem, and T. Mutis (2008)
J. Exp. Med. 205, 2863-2872
   Abstract »    Full Text »    PDF »
C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients.
S. S. Tykodi, N. Fujii, N. Vigneron, S. M. Lu, J. K. Mito, M. X. Miranda, J. Chou, L. N. Voong, J. A. Thompson, B. M. Sandmaier, et al. (2008)
Clin. Cancer Res. 14, 5260-5269
   Abstract »    Full Text »    PDF »
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
C. Schutz, M. Fleck, A. Mackensen, A. Zoso, D. Halbritter, J. P. Schneck, and M. Oelke (2008)
Blood 111, 3546-3552
   Abstract »    Full Text »    PDF »
Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA.
T. Kawase, Y. Nannya, H. Torikai, G. Yamamoto, M. Onizuka, S. Morishima, K. Tsujimura, K. Miyamura, Y. Kodera, Y. Morishima, et al. (2008)
Blood 111, 3286-3294
   Abstract »    Full Text »    PDF »
Identification of phosphatidylinositol 4-kinase type II {beta} as HLA class II-restricted target in graft versus leukemia reactivity.
M. Griffioen, E. D. van der Meijden, E. H. Slager, M. W. Honders, C. E. Rutten, S. A. P. van Luxemburg-Heijs, P. A. von dem Borne, J. J. van Rood, R. Willemze, and J. H. F. Falkenburg (2008)
PNAS 105, 3837-3842
   Abstract »    Full Text »    PDF »
TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
L. E. M. Oosten, D. Koppers-Lalic, E. Blokland, A. Mulder, M. E. Ressing, T. Mutis, A. G. S. van Halteren, E. J. H. J. Wiertz, and E. Goulmy (2007)
Int. Immunol. 19, 1115-1122
   Abstract »    Full Text »    PDF »
Characterizing MHC-Associated Peptides by Mass Spectrometry.
L. J. Stern (2007)
J. Immunol. 179, 2667-2668
   Full Text »    PDF »
Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen.
T. Kawase, Y. Akatsuka, H. Torikai, S. Morishima, A. Oka, A. Tsujimura, M. Miyazaki, K. Tsujimura, K. Miyamura, S. Ogawa, et al. (2007)
Blood 110, 1055-1063
   Abstract »    Full Text »    PDF »
Rebuilding Human Leukocyte Antigen Class II-Restricted Minor Histocompatibility Antigen Specificity in Recall Antigen-Specific T Cells by Adoptive T Cell Receptor Transfer: Implications for Adoptive Immunotherapy.
R. Spaapen, K. van den Oudenalder, R. Ivanov, A. Bloem, H. Lokhorst, and T. Mutis (2007)
Clin. Cancer Res. 13, 4009-4015
   Abstract »    Full Text »    PDF »
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene.
C. A. M. van Bergen, M. G. D. Kester, I. Jedema, M. H. M. Heemskerk, S. A. P. van Luxemburg-Heijs, F. M. Kloosterboer, W. A. E. Marijt, A. H. de Ru, M. R. Schaafsma, R. Willemze, et al. (2007)
Blood 109, 4089-4096
   Abstract »    Full Text »    PDF »
Natural Regulation of Immunity to Minor Histocompatibility Antigens.
N. J. Robertson, J.-G. Chai, M. Millrain, D. Scott, F. Hashim, E. Manktelow, F. Lemonnier, E. Simpson, and J. Dyson (2007)
J. Immunol. 178, 3558-3565
   Abstract »    Full Text »    PDF »
ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis.
N. Iwamoto, S. Abe-Dohmae, R. Sato, and S. Yokoyama (2006)
J. Lipid Res. 47, 1915-1927
   Abstract »    Full Text »    PDF »
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer.
E. H. Slager, M. W. Honders, E. D. van der Meijden, S. A. P. van Luxemburg-Heijs, F. M. Kloosterboer, M. G. D. Kester, I. Jedema, W. A. E. Marijt, M. R. Schaafsma, R. Willemze, et al. (2006)
Blood 107, 4954-4960
   Abstract »    Full Text »    PDF »
DNA Fusion Vaccines Induce Epitope-Specific Cytotoxic CD8+ T Cells against Human Leukemia-Associated Minor Histocompatibility Antigens..
J. Rice, S. Dunn, K. Piper, S. L. Buchan, P. A. Moss, and F. K. Stevenson (2006)
Cancer Res. 66, 5436-5442
   Abstract »    Full Text »    PDF »
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.
A. G. Brickner, A. M. Evans, J. K. Mito, S. M. Xuereb, X. Feng, T. Nishida, L. Fairfull, R. E. Ferrell, K. A. Foon, D. F. Hunt, et al. (2006)
Blood 107, 3779-3786
   Abstract »    Full Text »    PDF »
Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.
B. Mommaas, J. A. Stegehuis-Kamp, A. G. van Halteren, M. Kester, J. Enczmann, P. Wernet, G. Kogler, T. Mutis, A. Brand, and E. Goulmy (2005)
Blood 105, 1823-1827
   Abstract »    Full Text »    PDF »
A Novel HLA-A*3303-Restricted Minor Histocompatibility Antigen Encoded by an Unconventional Open Reading Frame of Human TMSB4Y Gene.
H. Torikai, Y. Akatsuka, M. Miyazaki, E. H. Warren III, T. Oba, K. Tsujimura, K. Motoyoshi, Y. Morishima, Y. Kodera, K. Kuzushima, et al. (2004)
J. Immunol. 173, 7046-7054
   Abstract »    Full Text »    PDF »
Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning: Toxicity, Clinical Response, and Immunological Response to Minor Histocompatibility Antigens.
S. S. Tykodi, E. H. Warren, J. A. Thompson, S. R. Riddell, R. W. Childs, B. E. Otterud, M. F. Leppert, R. Storb, and B. M. Sandmaier (2004)
Clin. Cancer Res. 10, 7799-7811
   Abstract »    Full Text »    PDF »
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes.
L. E. M. Oosten, E. Blokland, A. G. S. van Halteren, J. Curtsinger, M. F. Mescher, J. H. F. Falkenburg, T. Mutis, and E. Goulmy (2004)
Blood 104, 224-226
   Abstract »    Full Text »    PDF »
Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation.
E. Zorn, D. B. Miklos, B. H. Floyd, A. Mattes-Ritz, L. Guo, R. J. Soiffer, J. H. Antin, and J. Ritz (2004)
J. Exp. Med. 199, 1133-1142
   Abstract »    Full Text »    PDF »
Minor H Antigen HA-1-specific Regulator and Effector CD8+ T Cells, and HA-1 Microchimerism, in Allograft Tolerance.
J. Cai, J. Lee, E. Jankowska-Gan, R. Derks, J. Pool, T. Mutis, E. Goulmy, and W. J. Burlingham (2004)
J. Exp. Med. 199, 1017-1023
   Abstract »    Full Text »    PDF »
Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation.
N. Harashima, K. Kurihara, A. Utsunomiya, R. Tanosaki, S. Hanabuchi, M. Masuda, T. Ohashi, F. Fukui, A. Hasegawa, T. Masuda, et al. (2004)
Cancer Res. 64, 391-399
   Abstract »    Full Text »    PDF »
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein.
E. Spierings, A. G. Brickner, J. A. Caldwell, S. Zegveld, N. Tatsis, E. Blokland, J. Pool, R. A. Pierce, S. Mollah, J. Shabanowitz, et al. (2003)
Blood 102, 621-629
   Abstract »    Full Text »    PDF »
Minor Histocompatibility Antigens on Canine Hemopoietic Progenitor Cells.
M. Weber, C. Lange, W. Gunther, M. Franz, E. Kremmer, and H.-J. Kolb (2003)
J. Immunol. 170, 5861-5868
   Abstract »    Full Text »    PDF »
Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens.
Y. Akatsuka, T. Nishida, E. Kondo, M. Miyazaki, H. Taji, H. Iida, K. Tsujimura, M. Yazaki, T. Naoe, Y. Morishima, et al. (2003)
J. Exp. Med. 197, 1489-1500
   Abstract »    Full Text »    PDF »
A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion.
M. Murata, E. H. Warren, and S. R. Riddell (2003)
J. Exp. Med. 197, 1279-1289
   Abstract »    Full Text »    PDF »
Immunotherapy of Hematologic Malignancy.
H. E. Heslop, F. K. Stevenson, and J. J. Molldrem (2003)
Hematology 2003, 331-349
   Abstract »    Full Text »    PDF »
New Developments in Allotransplant Immunology.
A. J. Barrett, K. Rezvani, S. Solomon, A. M. Dickinson, X. N. Wang, G. Stark, H. Cullup, M. Jarvis, P. G. Middleton, and N. Chao (2003)
Hematology 2003, 350-371
   Abstract »    Full Text »    PDF »
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.
E. P. Hochberg, D. B. Miklos, D. Neuberg, D. A. Eichner, S. F. McLaughlin, A. Mattes-Ritz, E. P. Alyea, J. H. Antin, R. J. Soiffer, and J. Ritz (2003)
Blood 101, 363-369
   Abstract »    Full Text »    PDF »
Identification of a Novel HLA-B60-Restricted T Cell Epitope of the Minor Histocompatibility Antigen HA-1 Locus.
B. Mommaas, J. Kamp, J.-W. Drijfhout, N. Beekman, F. Ossendorp, P. van Veelen, J. den Haan, E. Goulmy, and T. Mutis (2002)
J. Immunol. 169, 3131-3136
   Abstract »    Full Text »    PDF »
The Hematopoietic System-specific Minor Histocompatibility Antigen HA-1 Shows Aberrant Expression in Epithelial Cancer Cells.
C. A. Klein, M. Wilke, J. Pool, C. Vermeulen, E. Blokland, E. Burghart, S. Krostina, N. Wendler, B. Passlick, G. Riethmueller, et al. (2002)
J. Exp. Med. 196, 359-368
   Abstract »    Full Text »    PDF »
Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells.
E. Zorn, K. S. Wang, E. P. Hochberg, C. Canning, E. P. Alyea, R. J. Soiffer, and J. Ritz (2002)
Clin. Cancer Res. 8, 2052-2060
   Abstract »    Full Text »    PDF »
Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
T. Mutis, E. Blokland, M. Kester, E. Schrama, and E. Goulmy (2002)
Blood 100, 547-552
   Abstract »    Full Text »    PDF »
The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
M. H. J. Vogt, J. W. van den Muijsenberg, E. Goulmy, E. Spierings, P. Kluck, M. G. Kester, R. A. van Soest, J. W. Drijfhout, R. Willemze, and J. H. F. Falkenburg (2002)
Blood 99, 3027-3032
   Abstract »    Full Text »    PDF »
General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses.
J. M. M. den Haan, T. Mutis, E. Blokland, A. P. IJzerman, and E. Goulmy (2002)
Blood 99, 985-992
   Abstract »    Full Text »    PDF »
Conservation of FceRI gamma chain coding region in normals and in SLE patients.
J Wu, J C Edberg, A W Gibson, and R P Kimberly (2002)
Lupus 11, 42-45
   Abstract »    PDF »
Down-Regulation of Antihost Alloreactivity after Bone Marrow Transplant Permits Relapse of Hematological Malignancy.
J. Wang, J. L. Shaw, and C. A. Mullen (2002)
Cancer Res. 62, 208-212
   Abstract »    Full Text »    PDF »
Tolerance or Immunity to a Tumor Antigen Expressed in Somatic Cells Can Be Determined by Systemic Proinflammatory Signals at the Time of First Antigen Exposure.
I. H. Frazer, R. D. Kluyver, G. R. Leggatt, H. Yang Guo, L. Dunn, O. White, C. Harris, A. Liem, and P. Lambert (2001)
J. Immunol. 167, 6180-6187
   Abstract »    Full Text »    PDF »
Absence of statistically significant correlation between disparity for the minor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation.
M.-T. Lin, T. Gooley, J. A. Hansen, L.-H. Tseng, E. G. Martin, K. Singleton, A. G. Smith, E. Mickelson, E. W. Petersdorf, and P. J. Martin (2001)
Blood 98, 3172-3173
   Full Text »    PDF »
The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein.
R. A. Pierce, E. D. Field, T. Mutis, T. N. Golovina, C. V. Kap-Herr, M. Wilke., J. Pool, J. Shabanowitz, M. J. Pettenati, L. C. Eisenlohr, et al. (2001)
J. Immunol. 167, 3223-3230
   Abstract »    Full Text »    PDF »
Quantitative Analysis of the Immune Response to Mouse Non-MHC Transplantation Antigens In Vivo: The H60 Histocompatibility Antigen Dominates Over All Others.
E. Y. Choi, Y. Yoshimura, G. J. Christianson, T. J. Sproule, S. Malarkannan, N. Shastri, S. Joyce, and D. C. Roopenian (2001)
J. Immunol. 166, 4370-4379
   Abstract »    Full Text »    PDF »
The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing.
A. G. Brickner, E. H. Warren, J. A. Caldwell, Y. Akatsuka, T. N. Golovina, A. L. Zarling, J. Shabanowitz, L. C. Eisenlohr, D. F. Hunt, V. H. Engelhard, et al. (2001)
J. Exp. Med. 193, 195-206
   Abstract »    Full Text »    PDF »
Non-Myeloablative Transplants for Malignant Disease.
R. F. Storb, R. Champlin, S. R. Riddell, M. Murata, S. Bryant, and E. H. Warren (2001)
Hematology 2001, 375-391
   Abstract »    Full Text »    PDF »
Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term Outcome.
H. M. Lokhorst, A. Schattenberg, J. J. Cornelissen, M. H. J. van Oers, W. Fibbe, I. Russell, N. W. C. J. v. d. Donk, and L. F. Verdonck (2000)
J. Clin. Oncol. 18, 3031-3037
   Abstract »    Full Text »    PDF »
Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1.
L. Gao, I. Bellantuono, A. Elsasser, S. B. Marley, M. Y. Gordon, J. M. Goldman, and H. J. Stauss (2000)
Blood 95, 2198-2203
   Abstract »    Full Text »    PDF »
Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy.
M. Brenner, C. Rossig, U. Sili, J. W. Young, and E. Goulmy (2000)
Hematology 2000, 356-375
   Abstract »    Full Text »    PDF »
Cutting Edge: The HLA-A*0101-Restricted HY Minor Histocompatibility Antigen Originates from DFFRY and Contains a Cysteinylated Cysteine Residue as Identified by a Novel Mass Spectrometric Technique.
R. A. Pierce, E. D. Field, J. M. M. den Haan, J. A. Caldwell, F. M. White, J. A. Marto, W. Wang, L. M. Frost, E. Blokland, C. Reinhardus, et al. (1999)
J. Immunol. 163, 6360-6364
   Abstract »    Full Text »    PDF »
Induction of Minor Histocompatibility Antigen HA-1-Specific Cytotoxic T Cells for the Treatment of Leukemia After Allogeneic Stem Cell Transplantation.
P. Brossart, B. Spahlinger, F. Grunebach, G. Stuhler, V. L. Reichardt, L. Kanz, W. Brugger;, T. Mutis, and E. Goulmy (1999)
Blood 94, 4374-4376
   Full Text »    PDF »
Allo-Major Histocompatibility Complex-Restricted Cytotoxic T Lymphocytes Engraft in Bone Marrow Transplant Recipients Without Causing Graft-Versus-Host Disease.
L. Gao, T.-H. Yang, S. Tourdot, E. Sadovnikova, R. Hasserjian, and H. J. Stauss (1999)
Blood 94, 2999-3006
   Abstract »    Full Text »    PDF »
Correlation Between Disparity for the Minor Histocompatibility Antigen HA-1 and the Development of Acute Graft-Versus-Host Disease After Allogeneic Marrow Transplantation.
L.-H. Tseng, M.-T. Lin, J. A. Hansen, T. Gooley, J. Pei, A. G. Smith, E. G. Martin, E. W. Petersdorf, and P. J. Martin (1999)
Blood 94, 2911-2914
   Abstract »    Full Text »    PDF »
Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes.
J.H. F. Falkenburg, A. R. Wafelman, P. Joosten, W. M. Smit, C. A.M. van Bergen, R. Bongaerts, E. Lurvink, M. van der Hoorn, P. Kluck, J. E. Landegent, et al. (1999)
Blood 94, 1201-1208
   Abstract »    Full Text »    PDF »
CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells.
D. Bonnet, E. H. Warren, P. D. Greenberg, J. E. Dick, and S. R. Riddell (1999)
PNAS 96, 8639-8644
   Abstract »    Full Text »    PDF »
Polyriboinosinic Polyribocytidylic Acid (Poly(I:C)) Induces Stable Maturation of Functionally Active Human Dendritic Cells.
R. M. Verdijk, T. Mutis, B. Esendam, J. Kamp, C. J. M. Melief, A. Brand, and E. Goulmy (1999)
J. Immunol. 163, 57-61
   Abstract »    Full Text »    PDF »
Common Intra-Articular T Cell Expansions in Patients with Reactive Arthritis: Identical {beta}-Chain Junctional Sequences and Cytotoxicity Toward HLA-B27.
N. Dulphy, M.-A. Peyrat, V. Tieng, C. Douay, C. Rabian, R. Tamouza, S. Laoussadi, F. Berenbaum, A. Chabot, M. Bonneville, et al. (1999)
J. Immunol. 162, 3830-3839
   Abstract »    Full Text »    PDF »
Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo-Generated Cytotoxic T Lymphocytes Specific for Hematopoietic System-Restricted Minor Histocompatibility Antigens.
T. Mutis, R. Verdijk, E. Schrama, B. Esendam, A. Brand, and E. Goulmy (1999)
Blood 93, 2336-2341
   Abstract »    Full Text »    PDF »
A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia.
H. Dolstra, H. Fredrix, F. Maas, P. G. Coulie, F. Brasseur, E. Mensink, G. J. Adema, T. M. de Witte, C. G. Figdor, and E. van de Wiel-van Kemenade (1999)
J. Exp. Med. 189, 301-308
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)